MC2 provides comprehensive solutions for your specific needs.
MC2 provides comprehensive solutions for your specific needs.
For MedTech companies bringing new technologies to market, MC2 provides guidance, strategy, and execution excellence to drive results-outperforming expectations consistently and cost effectively. We strive to integrate seamlessly with client teams to provide an external view and methodology that enhances a client’s perspective and augments their capabilities.
At MC2, we are committed to being the strategic partners in the medical device field, helping our clients navigate the complex journey from product inception to launch and throughout the product life-cycle.
We are committed to providing our clients with the highest level of service and delivering exceptional results. Our core values of integrity, transparency, and accountability guide everything we do, and we believe in building long-term relationships with our clients based on trust and mutual respect.
MC2 MedTech Commercial Consulting leverages 50+ years of experience from small growth VC backed early stage companies to very large Cap MedTech companies, to provide planning, strategy, structure, deliverables, and oversight through all stages from product inception to final commercialization. MC2 is your full service partner bringing new products to the North American market, expanding your geographic footprint globally, or validating existing strategy.
MC2 will leverage proven process methodologies in collaborating with your team to develop comprehensive and integrated solutions, de-risking your Product Realization challenges in an efficient and cost-effective manner.
Our team can validate your current strategies, structures, and execution effectiveness to provide independent guidance to your leadership team, board of directors, and investors.
MC2 also collaborates with university-based innovation engines on product realization to help monetize those early stage technologies and create a return on investment.
Scott has over 30 years of global experience across diverse business environments spanning Manufacturing, R&D, Marketing, Sales, and Project Management. Scott has held leadership positions bringing innovative new products to market in a variety of clinical indications for both large-cap and early stage medtech companies. As Vice Preside
Scott has over 30 years of global experience across diverse business environments spanning Manufacturing, R&D, Marketing, Sales, and Project Management. Scott has held leadership positions bringing innovative new products to market in a variety of clinical indications for both large-cap and early stage medtech companies. As Vice President of Product Realization and Senior Director of Marketing for Power Medical Interventions (PMI), Mr. Brown led the development and commercialization of the first intelligent powered surgical stapling system which led to PMI’s initial public offering (IPO). Following an acquisition by Covidien, Mr. Brown led the go-to-market strategy development and initial commercialization activities across Europe for the stapling platform. Mr. Brown then went on to launch new products and develop new markets for OmniGuide Surgical, Integra Lifesciences, and others, receiving various recognition awards in the process.
A former Project Management Professional (PMP), Mr. Brown received his M.B.A. in Management from Saint Joseph’s Haub School of Business. Mr. Brown also has an M.S. in Manufacturing Engineering from Brigham Young University, a Master’s Certificate in Project Management from George Washington University, and a B.S. in Mechanical Engineering from Virginia Tech.
A lifelong athlete, Mr. Brown has coached, and still plays soccer and basketball, and enjoys other adrenalin generating sports when the weather is good.
Executive Leader of Large Cap Medical Device
Commercial Business and Operations - Medtronic, etc
Jim has driven exceptional results over time at both small venture-backed MedTech companies and Medtronic (large cap), and has advised on numerous topics including strategy, structure, and execution to both.
Over a distinguished 18 year career
Executive Leader of Large Cap Medical Device
Commercial Business and Operations - Medtronic, etc
Jim has driven exceptional results over time at both small venture-backed MedTech companies and Medtronic (large cap), and has advised on numerous topics including strategy, structure, and execution to both.
Over a distinguished 18 year career at Medtronic, Mr. Komsa was most recently Vice President of the Restorative Therapy Group (RTG) and the U.S. Pain Organization, with annual sales of $400 million and $1.1 billion, respectively, at the time. There, he was responsible for 16 business units, including Medtronic Spine, Neurology, ENT, Pain and others. Prior to that, Jim led the successful turnaround of Interventional Spine (Kyphon) as U.S. Vice President Medtronic Spine Division. Formerly as Vice President, Northeast Region, Medtronic Cardiac and Vascular Group (CVG), Mr. Komsa was responsible for sales, marketing and operations for the Coronary, Pacemakers, Defibrillators, Structural Heart, Endovascular, and Cardiac Rhythm Disease Management business units, encompassing more than 300 full-time employees and generating approximately $400 million in annual sales.
Prior to his career at Medtronic, Jim was Vice President at Hambrecht & Quist, where he helped lead the operations and drove rapid sales growth of two start-up companies, Paceart and Zymed, which were ultimately acquired by Medtronic and Philips, respectively.
Jim has a Biology and business background. Dartmouth College - Biology degree and Tuck School of Business - Tuck Executive Program.
Jim is competitive and enjoys building high performing organizations and cultures. He has been recognized with numerous business awards. Jim played D1 Soccer at Dartmouth, still coaches and competes in other sports and has a track record of winning at all personal and professional levels.
MC2 will leverage proven process methodologies in collaborating with your team to develop comprehensive and integrated solutions, de-risking your Product Realization challenges in an efficient and cost-effective manner.
Our 3-phase proven Product Realization Process includes:
With broad clinical experience, coupled with deep functional expertise and a consistent long-term winning track record in commercializing Class II & III medical devices, in start-ups to the largest device firms, MC2 is uniquely positioned to provide experience-based custom solutions designed to fit your needs. We will build strategy, str
With broad clinical experience, coupled with deep functional expertise and a consistent long-term winning track record in commercializing Class II & III medical devices, in start-ups to the largest device firms, MC2 is uniquely positioned to provide experience-based custom solutions designed to fit your needs. We will build strategy, structure, and execution plans designed to maximize corporate value or drive alignment with exit strategies.
Our work is based on real-life experience with exceptional results over time and diverse business environments (start-up to large cap) across a variety of clinical indications (cardiac, vascular, spine, neuro, surgery, wound, pain navigation, etc).
During the product development phase and pre-regulatory, MC2 can provide a project management plan ensuring all details are covered and realistic timelines are established and tracked. Manufacturing guidance, timeline tracking and timing visibility can be inserted into this phase in a rapid and highly cost effective manner. Claims guidance, validation and audit can be provided to be compliant and ultimately maximize the economic value proposition (EVP).
Our global regulatory consulting services are specifically catered to meet each Client's individual needs. Our comprehensive approach to consulting ensures that you have a trustworthy and reliable partner throughout the entire process. We are dedicated to exceeding your expectations and ensuring your overall success.
Based on your specific needs, we will deliver comprehensive regulatory submissions / reports, and project deliverables in accordance with an agreed upon project plan which outlines applicable timelines and/or milestones, cost analyses, and a schedule for project completion
MC2 has strong experience with Sales Structure. We can analyze the commercial landscape specific to your product and model Direct, Distributor, and Hybrid Sales options with pros/cons, success probabilities and costs associated.
We provide expertise on Compensation models, Sales Incentive programs, Engagement, KPIs, analytics and tracking.
We can outline optimal span of control, review long term vs short term drivers, and provide ongoing management guidance or full time Sales Management as needed.
Expected ROI and Planning deliverables are also available.
We specialize in Market analysis, providing Total Available Market(TAM) studies, EVP modeling, and effective and compliant EVP marketing collateral. Your team, your board and your investors can make educated decisions based on validated market analytics.
MC2’s team has extensive experience in Commercialization and can provide comprehensive modeling, reports, tracking tools, P&Ls, and Cash requirement reports, Sales structure analysis and recommendations, and full go-to-market playbook for launch. We leverage experience to reduce risk and save you time and money.
We can be a full marketing resource, or we can provide your company with specific components as needed. Marketing collateral, Sell sheets, digital resources, design services, effectiveness reporting, and other Medtech deliverables are available through ongoing contract agreement or a la carte.